EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of extracellular microRNAs as potential biomarker candidates for assessing chlamydia reinfection risk

Chloe Meewes Lewis iD, Kanupriya Gupta, Howard Wiener, Hemant K Tiwari, William M Geisler

PLOS One · 18.08.2026 · 21 (8) · e0356267

DOI: 10.1371/journal.pone.0356267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.08.2026. Verfasst von Chloe Meewes Lewis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America. Hauptthemen laut MEDLINE: MicroRNAs, Chlamydia Infections, Chlamydia trachomatis, Reinfection. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chlamydia trachomatis infection remains prevalent, with high rates of reinfection. Most infections are asymptomatic, and without treatment, women are at risk for reproductive and perinatal complications that are exacerbated with repeat infections. Currently, no C. trachomatis vaccine is available nor are there clinical biomarkers to predict reinfection risk. Small, non-coding microRNAs (miRNAs) are promising biomarker candidates because of their easy isolation, high stability, and role as molecular messengers. MiRNAs can be intracellular and/or extracellular, with the latter being released from cells and either packaged into extracellular vesicles (EVs) or freely circulating in association with proteins. We identified miRNAs from serum EVs and whole serum collected from 42 women (53 samples) and 35 women (49 samples), respectively. Sera were collected at a baseline treatment visit and a 3-month follow-up visit, where women were determined to be reinfected or not reinfected by nucleic acid amplification test. MiRNA profiles were evaluated using Bruker nCounter microarrays, data were positive ligation normalized, miRNAs were categorized as detected or not detected, nominal significance was calculated using Fisher’s exact test, and predicted target mRNAs were assessed with Qiagen’s Ingenuity Pathway Analysis (IPA). Detection of EV-derived miR-888-5p at baseline was associated with reinfection at the follow-up visit. For whole serum, detection of miR-1285-5p, −548aa + 548t-3p, and −575 at baseline were associated with absence of reinfection at follow-up. MiRs-888-5p and −548aa aligned with varying degrees to mRNA targets associated with CD8+ and CD4 + T-cell functions, with miR-888-5p demonstrating strong CD8 + T-cell associations while miR-548aa was largely associated with CD4 + T-cell responses. Distinct EV and whole serum miRNAs were identified as potential biomarker candidates that are associated with reinfection risk. Our findings are preliminary, and future work includes validation studies to confirm whether these miRNAs can predict C. trachomatis reinfection risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsChlamydia InfectionsChlamydia trachomatisReinfectionHumansFemaleBiomarkersExtracellular VesiclesAdult

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

ORCID-Profile: Chloe Meewes Lewis

Förderung

  • NIAID NIH HHS
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Lewis, C. M., Gupta, K., Wiener, H., Tiwari, H. K., & Geisler, W. M. (2026). Evaluation of extracellular microRNAs as potential biomarker candidates for assessing chlamydia reinfection risk. PLOS One, 21(8), e0356267. https://doi.org/10.1371/journal.pone.0356267

Vancouver

Lewis CM, Gupta K, Wiener H, Tiwari HK, Geisler WM. Evaluation of extracellular microRNAs as potential biomarker candidates for assessing chlamydia reinfection risk. PLOS One. 2026;21(8):e0356267. doi:10.1371/journal.pone.0356267

BibTeX
@article{Lewis2026,
  author = {Lewis, Chloe Meewes and Gupta, Kanupriya and Wiener, Howard and Tiwari, Hemant K and Geisler, William M},
  title = {Evaluation of extracellular microRNAs as potential biomarker candidates for assessing chlamydia reinfection risk},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0356267},
  doi = {10.1371/journal.pone.0356267}
}
Kostenlos starten →